🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
The goal of this clinical trial is to demonstrate the non-inferiority of tr...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2025-04-01
Trial ID
NCT06992648
Treatments Being Tested
This is a two-group, parallel, randomized, standard-control phase II study ...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-09-01
Trial ID
NCT05077839
Treatments Being Tested
The dual immunotherapy regimen significantly outperformed previous chemothe...
Status
Recruiting
Location
Zhongshan hosptial, Fudan University
Start Date
2024-01-01
Trial ID
NCT06218810
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
The high-grade malignant brain tumors, glioblastoma multiforme (GBM) and an...
Status
Recruiting
Location
Lenox Hill Brain Tumor Center
Start Date
2010-10
Trial ID
NCT01269853
Treatments Being Tested
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Status
Recruiting
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Start Date
2025-10-16
Trial ID
NCT07213570
Treatments Being Tested
The BRAVE is a phase II clinical trial aimed at evaluating the efficacy of ...
Status
Recruiting
Location
Vall d'Hebron Hospital
Start Date
2024-05-17
Trial ID
NCT06411600
Treatments Being Tested
This is a randomized, controlled, double-blind, placebo-controlled trial of...
Status
Completed
Location
Stanford University Department of Otolaryngology- Head and Neck Surgery
Start Date
2014-08-04
Trial ID
NCT02389959
Treatments Being Tested